Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Tenosynovial Giant Cell Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Tenosynovial Giant Cell Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tenosynovial Giant Cell Tumor Drugs in Development by Stages, Target, MoA, RoA, Mo...
May 2022
42 pages
Testicular Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Testicular Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Testicular Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
46 pages
Thrombocytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Thrombocytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thrombocytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
106 pages
Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...
May 2022
151 pages
Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
70 pages
Thymoma (Thymic Epithelial Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Thymoma (Thymic Epithelial Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Thymoma (Thymic Epithelial Tumor) Drugs in Development by Stages, Target, MoA,...
May 2022
81 pages
Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, R...
May 2022
37 pages
Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Mo...
May 2022
37 pages
Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...
May 2022
53 pages
Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Mole...
May 2022
37 pages
Travelers Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Travelers Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Traveler's Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key P...
May 2022
41 pages
Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA,...
May 2022
81 pages
Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
133 pages
Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
46 pages
Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
US$ 3,500.00
Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...
May 2022
247 pages
Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
35 pages
Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...
May 2022
57 pages
Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Mole...
May 2022
41 pages
Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...
May 2022
70 pages
